There is no single best treatment for vascular dementia, and no medication can reverse the brain damage that causes it. The most effective approach combines preventing further strokes, managing cardiovascular risk factors, and using non-drug strategies to maintain cognitive function and quality of life as long as possible. Median survival after a dementia diagnosis is about 5 years, so the earlier these interventions begin, the more meaningful their impact.
Why Prevention Is the Primary Treatment
Vascular dementia results from reduced blood flow to the brain, usually caused by strokes or chronic small vessel disease. Unlike Alzheimer’s, where abnormal proteins accumulate gradually, vascular dementia often progresses in a stepwise pattern: each new stroke or vascular event causes another drop in cognitive function. This means preventing additional damage to the brain’s blood supply is the single most important treatment strategy.
Repeated strokes are directly linked to worsening cognitive decline and a higher risk of death. Antiplatelet medications like aspirin and clopidogrel reduce the risk of recurrent strokes in people with confirmed cerebrovascular disease. Research on acute ischemic stroke survivors found that those taking antiplatelet agents had better functional and cognitive outcomes than those who did not. Most physicians treat vascular dementia patients with these medications as part of standard secondary stroke prevention.
Blood Pressure and Cardiovascular Risk
Controlling blood pressure is one of the few interventions with strong evidence behind it. A major randomized clinical trial found that targeting a systolic blood pressure below 120 mmHg, compared to the standard target of below 140 mmHg, reduced cardiovascular events and overall mortality. Critically, this intensive approach also significantly reduced the occurrence of mild cognitive impairment, a common precursor to dementia, and was confirmed to be safe for the brain.
Beyond blood pressure, the broader cardiovascular picture matters. Managing cholesterol, controlling blood sugar if you have diabetes, quitting smoking, and maintaining a healthy weight all reduce the strain on blood vessels feeding the brain. These aren’t optional add-ons. For vascular dementia specifically, they are core treatment.
What Medications Can (and Can’t) Do
The medications most commonly associated with dementia treatment, called cholinesterase inhibitors, are actually licensed for Alzheimer’s disease, not vascular dementia. Still, they are sometimes prescribed off-label. A large network meta-analysis found that donepezil at a higher dose (10 mg) had the greatest effect on cognition in people with vascular cognitive impairment, improving scores on a standard cognitive test by about 2.2 points on a 70-point scale. Galantamine showed a similar modest benefit of about 2 points. Rivastigmine appeared to have little to no effect.
Those improvements, while statistically real, are unlikely to be noticeable in daily life. The researchers themselves noted the effects “may not be clinically important.” The higher dose of donepezil also came with nearly double the rate of side effects compared to placebo, including nausea, vomiting, diarrhea, and dizziness. Galantamine carried a smaller but still measurable increase in adverse events.
Despite these limitations, some people with vascular dementia still choose to try these medications. In the absence of better pharmacological options, even a small cognitive benefit may feel worthwhile. That decision is personal and depends on how well you tolerate the side effects.
Non-Drug Approaches That Help
Non-pharmacological strategies often deliver more practical benefit than medication for people in the mild to moderate stages. Cognitive stimulation programs, which involve structured group activities designed to engage thinking and memory, consistently produce improvements in general cognition and, in some cases, self-reported quality of life. These programs work best when started early, while the person still has enough cognitive reserve to participate actively and build compensatory habits.
Cognitive rehabilitation takes a more individualized approach. Rather than general brain exercises, it focuses on specific daily challenges the person faces, such as remembering a medication schedule or navigating familiar routes. A therapist helps develop strategies like visual cues, simplified routines, or memory aids tailored to the person’s life. Early evidence from randomized trials shows promising results for both the person with dementia and their caregiver.
Strategy training is another technique gaining attention. It teaches specific methods for working around memory gaps, such as using mental imagery to encode new information or breaking tasks into smaller steps. The goal is to extend independence in daily activities for as long as possible, reducing what clinicians call “excess disability,” the gap between what someone can still do and what they actually do because of lack of support or confidence.
Managing Agitation and Mood Changes
Behavioral symptoms like agitation, irritability, and depression are common in vascular dementia, and they can be more distressing for families than the memory loss itself. Current guidelines recommend non-drug approaches as the first line of treatment, not medication.
Person-centered care, where routines, activities, and communication are tailored to the individual’s history, personality, and preferences, has been shown to reduce agitation in both home and care home settings and decrease the use of antipsychotic drugs. Music therapy, particularly in group settings, significantly reduces agitation. Live social interaction is one of the most effective single activities, partly because boredom itself is a trigger for physical agitation in people with dementia.
Other approaches being used include aromatherapy, bright light therapy, spending time outdoors, and sensory stimulation. Good sleep hygiene and minimizing physical restraints also help prevent episodes. When behavioral symptoms are severe enough to pose safety risks, antipsychotic medications have the strongest evidence for effectiveness, but their well-known side effects (including increased stroke risk in older adults with dementia) limit their use to situations where non-drug strategies have failed.
Diet and Physical Activity
The MIND diet, a hybrid of Mediterranean and heart-healthy eating patterns, has been linked to slower cognitive decline. It emphasizes green leafy vegetables, other vegetables, berries, whole grains, beans, nuts, and at least one weekly serving of fish, while limiting red meat, sweets, cheese, fast food, and fried foods. People with the highest adherence had a 4% reduced risk of cognitive impairment compared to those with the lowest adherence. The benefit was more pronounced in women, with an 8% lower risk of cognitive decline.
Those numbers may sound modest, but diet works alongside every other intervention. Combined with blood pressure control, physical activity, social engagement, and cognitive stimulation, the cumulative effect is substantially larger than any single strategy alone. Regular aerobic exercise improves blood flow to the brain and has independent benefits for balance, mobility, and mood, all of which matter for maintaining daily function.
What Treatment Looks Like in Practice
The reality of managing vascular dementia is that it involves layering multiple strategies rather than relying on any single treatment. A typical plan might include a daily antiplatelet medication, aggressive blood pressure management, dietary changes, a structured exercise routine, weekly cognitive stimulation sessions, and environmental modifications at home to support independence. For caregivers, learning person-centered communication techniques can reduce behavioral crises and improve quality of life for everyone involved.
Once someone with dementia moves into institutional care, median survival is about 2.5 years. This underscores why early, comprehensive management matters. The treatments available today cannot cure vascular dementia, but they can meaningfully slow its progression, preserve function, and improve the years that remain.